|
⚲
|
| PSP Research LLC
✚
|
|
|---|---|
| CRD # | 333271 |
| SEC # | 801-131402 |
| CIK # | 0002106939 |
| AUM | $178.6 M (2026-02-27) |
| Employees | 1 (100% Investors, 0% Brokers) |
| Phone | 617-483-5981 |
| Address | |
| Source | [IAPD] [EDGAR] |
| Total AUM ($M) |
|---|
| CIK | Period |
|---|---|
| 0002106939 |
| Sector | Form 13F Holdings | Value ($M) | |
|---|---|---|---|
| Royalty Pharma PLC | 0.6 | ||
| Nurix Therapeutics Inc | 0.6 | ||
| Incyte Corp | 0.6 | ||
| Argenx SE | 0.6 | ||
| FS Development Corp | 0.6 | ||
| Rapport Therapeutics Inc | 0.6 | ||
| Ultragenyx Pharmaceutical Inc | 0.6 | ||
| Trevi Therapeutics Inc | 0.6 | ||
| Monte Rosa Therapeutics Inc | 0.6 | ||
| Manhattan Pharmaceuticals Inc | 0.5 | ||
| Halozyme Therapeutics Inc | 0.5 | ||
| ISIS Pharmaceuticals Inc | 0.5 | ||
| Pharvaris NV | 0.5 | ||
| Arcutis Biotherapeutics Inc | 0.5 | ||
| Aurinia Pharmaceuticals Inc | 0.5 | ||
| Neurocrine Biosciences Inc | 0.5 | ||
| Health Sciences Acquisitions Corp | 0.5 | ||
| Acadia Pharmaceuticals Inc | 0.5 | ||
| PTC Therapeutics Inc | 0.5 | ||
| Celldex Therapeutics Inc | 0.5 | ||
| Immunocore Holdings PLC | 0.5 | ||
| MIND Medicine Mindmed Inc | 0.5 | ||
| UNUM Therapeutics Inc | 0.5 | ||
| Kymera Therapeutics Inc | 0.5 | ||
| Dyne Therapeutics Inc | 0.4 | ||
| Alnylam Pharmaceuticals Inc | 0.4 | ||
| Tarsus Pharmaceuticals Inc | 0.4 | ||
| Syndax Pharmaceuticals Inc | 0.4 | ||
| Prev | Page 1 | Next | |||
| AUM Breakdown | Accounts | AUM ($M) |
|---|---|---|
| By Client Type | ||
| (a) Individuals (other than high net worth individuals) | 0 | 0.0 |
| (b) Individuals (high net worth individuals) | 0 | 0.0 |
| (c) Banking or thrift institutions | 0 | 0.0 |
| (d) Investment companies | 0 | 0.0 |
| (e) Business development companies | 0 | 0.0 |
| (f) Pooled investment vehicles | 0 | 0.0 |
| (g) Pension and profit sharing plans | 0 | 0.0 |
| (h) Charitable organizations | 0 | 0.0 |
| (i) State or municipal government entities | 0 | 0.0 |
| (j) Other investment advisers | 0 | 0.0 |
| (k) Insurance companies | 0 | 0.0 |
| (l) Sovereign wealth funds and foreign official institutions | 0 | 0.0 |
| (m) Corporations or other businesses not listed above | 0 | 178.6 |
| (n) Other | 0 | 0.0 |
| Total | 1 | 178.6 |
| By Discretionary | ||
| Discretionary | 1 | 178.6 |
| Non-Discretionary | 0 | 0.0 |
| Total | 1 | 178.6 |
| By Non-United States Persons | ||
| Non-United States Persons | 178.6 | |
| United States Persons | 0.0 | |
| Total | 1 | 178.6 |
| EDGAR Form | CIK | 2011 - 2026 |
|---|---|---|
| 13F-HR | [0002106939] |
| Comparable Firms | State | AUM ($B) |
|---|---|---|
|
GSI Capital Advisors LLC
✚
|
CA | 0.2 |
|
Bradesco Global Advisors Inc
✚
|
FL | 0.2 |
|
Square Nine Capital LP
✚
|
CA | 0.2 |
|
Maroon PASS Advisors LP
✚
|
TX | 0.2 |
|
Totus Alpha Management PTY Ltd
✚
|
0.2 | |
|
Highbury Park LLC
✚
|
0.2 | |
|
Advisorengine Portfolio Solutions Inc
✚
|
NC | 0.2 |
|
Summerhaven Investment Management LLC
✚
|
CT | 0.2 |
|
Routeburn Capital LP
✚
|
0.2 | |
|
Port Street Investments LLC
✚
|
CA | 0.2 |